Evaluation of bleeding in patients receiving direct oral anticoagulants

Direct oral anticoagulants (DOACs) are recognized by evidence-based treatment guidelines as the first-line option for the treatment of venous thromboembolism and prevention of stroke and systemic embolism in nonvalvular atrial fibrillation. As use of these anticoagulants has become favored over the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hellenbart, Erika L, Faulkenberg, Kathleen D, Finks, Shannon W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574591/
https://www.ncbi.nlm.nih.gov/pubmed/28860793
http://dx.doi.org/10.2147/VHRM.S121661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5574591/
https://www.ncbi.nlm.nih.gov/pubmed/28860793
http://dx.doi.org/10.2147/VHRM.S121661

Ejemplares similares